News. 11/12/19

Fidelix invests in Lansen Systems AB to strengthen smart sensors offering

Fidelix Holding Oy has on 10th of December acquired 40% of the shares of Lansen Systems AB, the leader in developing smart metering solutions technology.

Lansen Systems AB is a Swedish hardware provider focused on submetering and wireless solutions. Lansen Systems AB has been developing and manufacturing sensor systems for more than 10 years and has grown very rapidly and has been successful in serving many large clients in Europe.

Fidelix is a pioneer in smart buildings and indoor climate control. Fidelix will strengthen the product and service portfolio in residential sector to help contractors and building owners to meet EU’s energy efficiency requirements in residential buildings and apartments. EU’s Energy Efficiency Directive requires individual measurement devices to be installed in residential buildings and apartments.

“Lansen has impressive product portfolio of high quality wireless sensors to meet the future needs of smart residential buildings. We are excited to continue together our journey in making buildings smart and sustainable.” says Tero Kosunen, CEO Fidelix.

“We are excited to get this opportunity to deepen the cooperation with Fidelix group. We strongly believe that Fidelix will further increase our access to residential building owners especially in Sweden and in Finland. Together we will be even stronger in digitalization of buildings in the European market.” says Patrick Simpson, one of the founders of Lansen.

The acquisition has no impact on the employees of Lansen or Fidelix. The proforma net sales of Fidelix group is over 40 MEUR and Fidelix group employs more than 300 people.

More Information:
Tero Kosunen, Fidelix, CEO, tel. +358 50 444 1200

Fidelix is making buildings smart
Our high expertise in technologies is visible in solutions optimizing buildings energy costs, indoor climate and cost of operations. Our products are developed, tested and working every day in demanding and extreme climate conditions in the Nordics and positively affect the wellbeing of over one million people.

www.fidelix.fi

Lansen Wireless Building Technology
Lansen is a European hardware provider focused on submetering and wireless solutions.

We design and manufacture smart metering products mainly built on the Wireless M-BUS and OMS standard. We provide products with our brand as well as customized OEM products.

Highest quality and innovation are our keywords.

www.lansensystems.com

Read more

Fidelix invests in Lansen Systems AB to strengthen smart sensors offering.

Fidelix investerar i Lansen Systems AB för att stärka erbjudandet inom trådlösa sensorer och radioinfrastruktur.

Fidelix investoi ruotsalaisyritykseen vahvistaakseen älykkään mittaamisen tarjontaa.

More news.

09/04/24

Polarn O. Pyret appoints Sara Sjöberg as new CEO

Procuritas Capital Investors VI (”Procuritas”), the Swedish private equity firm dedicated to growing Nordic mid-market enterprises, is delighted to announce the appointment of Sara Sjöberg as the forthcoming Chief Executive Officer for its portfolio company, Polarn O. Pyret, the iconic Swedish childrenswear brand. Sara Sjöberg steps into this role with a wealth of experience from...

08/04/24

Humana to acquire Team Olivia’s Norwegian operation

Team Olivia, a leading care service provider in the Nordics has entered into an agreement to sell its Norwegian operations, Team Olivia Norge AS, to Human Care Holding AS (“Humana”). The Transaction is subject to approval by the Norwegian competition authority and is expected to be completed during the second quarter of 2024. Team Olivia,...

28/02/24

Procuritas partners up with Precision BioLogic

Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to...